Serum chemokine network correlates with chemotherapy in non-small cell lung cancer. Issue 1 (28th August 2015)

• Record Type: Journal Article
• Authors: Yang, Dawei; Zhou, Jian; Zeng, Tao; Yang, Zhiyuan; Wang, Xun; Hu, Jie; Song, Yuanlin; Chen, Luonan; Peer, Dan; Wang, Xiangdong; Bai, Chunxue
• Is Part Of: Cancer letters. Volume 365:Issue 1(2015)
• Page Start: 57
• Page End: 67
• Publication Date: 2015-08-28
• Subjects: Cancer -- Periodicals; Neoplasms -- Periodicals; Cancer -- Périodiques; Electronic journals; 616.994
• DOI: 10.1016/j.canlet.2015.05.001
• Languages: English
• ISSNs: 0304-3835

Abstract

<abstract abstract-type="author-highlights" id="ab0010"> <title id="st0010">Highlights</title> <sec> <p id="sp0010"> <list id="ulist0010"> <list-item id="u0010"> <label></label> <p id="p0010">We analyzed the relationships of inflammatory biomarker networks with non-small cell lung cancer (NSCLC) therapies.</p> </list-item> <list-item id="u0015"> <label></label> <p id="p0015">Cytokine network in NSCLC was similar to that of normal persons after multiple courses of chemotherapy.</p> </list-item> <list-item id="u0020"> <label></label> <p id="p0020">MIP-3α was the most crucial biomarker for predicting survival rates in NSCLC patients.</p> </list-item> <list-item id="u0025"> <label></label> <p id="p0025">NSCLC-specific profile of inflammation mediators may improve clinical outcomes of NSCLC patients.</p> </list-item> </list> </p> </sec> </abstract>